Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Intravenous (IV) Therapy and Vein Access Market by Product Type (Implantable Port [Single Lumen Implantable Port and Double Lumen Implantable Port], Intravenous Catheter [Peripheral Intravenous Catheter, Central Intravenous Catheter, and Peripherally Inserted Central Catheter], Hypodermic Needles, Infusion Pumps, and Other Products), Medical Application (Volume Expanders, Medication Administration, Blood-based Products, and Nutrition & Buffer Solution), and End User (Hospitals, Ambulatory Surgical Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_172350
Pages: 175
Jun 2017 | 1707 Views
face gplus_n
Author's : Abha Thakur
Tables: 49
Charts: 24
twit_n pr_n

Intravenous (IV) Therapy and Vein Access Market:

Global Intravenous Therapy And Vein Access Devices Market accounted for $18,000 million in 2016, and is estimated to reach $27,971 million by 2023, growing at a CAGR of 6.4% from 2017 to 2023. The increase in the number of surgeries and utilization of intravenous therapy devices is due to high prevalence of chronic diseases worldwide.

The key factors that drive the growth of IV therapy and vein access devices market include rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the analysis period. However, dearth of experienced healthcare professionals restricts the market growth.

Intravenous Therapy and Vein Access Devices Market Segmentation

Intravenous Therapy and Vein Access Devices Market Segmentation

Segment Review

Based on product, the global IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. The intravenous catheter segment accounted for the highest market share, and is expected to witness the highest growth rate during the forecast period. Owing to the growth of the intravenous catheter market is fueled by the rise in use of intravenous catheter during surgical procedures for IV therapies and during blood and medicine transfer and other nutrients to different parts of the body. On the basis of application, medication administration held the highest market share, owing to the high usage of IV therapy for transferring the medicines for diseases such as diabetes, cancer, and others. Based on end user, hospitals held the highest market share as large number of surgeries are performed in it as compared to ambulatory surgical centers, and clinics.

Top Investment Pocket

Intravenous Therapy and Vein Access Devices Market Top investment pocket

Geographical Review

Geographically, the global IV therapy & vein access devices market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest share of the market in 2016, followed by Europe.

Conversely, Asia-Pacific is anticipated to grow at the highest rate regionally during the analysis period, due to increase in pool of patient population, rise in prevalence of road accidents, surge in trauma cases, and increase in government investments for the development of better healthcare facilities and R&D activities. Asia-Pacific is expected to emerge as the area with maximum growth potential due to the focus of key players in the emerging economies and improvement in healthcare infrastructure.

Mexico Intravenous Therapy and Vein Access Devices Market ($Million), 2016-2023

Mexico Intravenous Therapy and Vein Access Devices Market ($Million), 2016-2023

Increase in Geriatric Population

Decrease in fertility rate and increase in life expectancy have led to increase in geriatric population over the past few years. According to the U.S. Census Bureau report, An Aging World: 2015, currently 8.5% of world population comprises population aged 65 and over, and this percentage is predicted to increase nearly 17% by 2050. At present, Asia-Pacific leads globally in speed of aging and size of older population and would continue to lead during the forecast period.

Increase in Prevalence of Chronic Diseases

Over the past few decades, increase in prevalence of diseases and trauma cases have reached an alarming proportion. According to WHO, chronic diseases, such as diabetes, cardiovascular disorders, cancer, and chronic respiratory diseases, lead to death of 70% population globally in 2012. Intravenous therapies are useful for the treatment of diseases, such as diabetes, cancer, pain management, and others, which require timely administration of drugs and therapeutics with faster treatment. According to the National Center for Biotechnology Information (NCBI), around 285 million people were affected with diabetes worldwide in 2010, and the number is estimated to reach 439 million by 2030. Increase in prevalence of diabetes has significantly fueled the demand for intravenous therapy. The bioavailability and action of the drug administered through intravenous routes is rapid as compared to other routes such as oral, topical, and enteral. Thus, most healthcare professionals are employing infusion & injection therapies, as they are ideal for a successful prognosis. This is anticipated to boost the market growth in the future.

The major companies operating in this market have adopted product launch as their key development strategy. Companies profiled in this market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Medical Corporation, Teleflex Medical Inc., Medtronic Inc., Smith & Nephew plc, AngioDynamics, Inc., Pfizer Inc., Insulet Corporation, and Fresenius SE & Co. KGaA.

The other players (the profiles of these players are not covered in the report) in the value chain include, Baxter International Inc., iRadimed Corporation, BioScrip, Inc., Grifols, S.A., JW Life Science Co. Ltd., BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd., CVS Health Corporation, and Vifor Pharma Group.

Key Market Benefits

  • The study provides an in-depth analysis of the IV therapy and vein access devices market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders capitalize on prevailing market opportunities.
  • Extensive analysis by product, application, and end user helps to understand various trends and prevailing opportunities in the respective market.
  • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies.
  • Key market players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Intravenous (IV) Therapy and Vein Access Market Key Segments:

By Product

  • Implantable Ports
    • Single Lumen Implantable Port
    • Double Lumen Implantable Port
  • Intravenous Catheters
    • Peripheral Intravenous Catheter
    • Central Intravenous Catheter
    • Peripherally Inserted Central Catheter
  • Hypodermic Needles
  • Infusion Pumps
  • Other Products

By Medical Application

  • Volume Expanders
  • Medication Administration
  • Blood-based Products
  • Nutrition &Buffer Solution

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENT
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1.KEY FINDINGS OF THE STUDY
2.2.CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTER’S FIVE FORCES ANALYSIS

3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of substitutes
3.3.4.Threat of new entrants
3.3.5.Competitive rivalry

3.4.TOP PLAYERS POSITIONING, 2016
3.5.MARKET DYNAMICS

3.5.1.Drivers

3.5.1.1.Increase in geriatric population
3.5.1.2.Increase in prevalence of chronic diseases
3.5.1.3.Increase in trauma cases and traffic accidents
3.5.1.4.Wide advantages of IV therapy and vein access devices

3.5.2.Restraint

3.5.2.1.Risk of allergic reaction and requirement of skilled professionals
3.5.2.2.Stringent government regulations

3.5.3.Opportunity

3.5.3.1.Lucrative opportunities from emerging economies

Chapter: 4 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.IMPLANTABLE PORT

4.2.1.Key market trends
4.2.2.Key growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Single Lumen Implantable Port

4.2.4.1.Market size and forecast

4.2.5.Double Lumen Implantable Port

4.2.5.1.Market size and forecast

4.3.INTRAVENOUS CATHETER

4.3.1.Key market trends
4.3.2.Key growth factors and opportunities
4.3.3.Market size and forecast
4.3.4.Peripheral Intravenous Catheter

4.3.4.1.Market size and forecast

4.3.5.Central Intravenous Catheter

4.3.5.1.Market size and forecast

4.3.6.Peripherally Inserted Central Catheter

4.3.6.1.Market size and forecast

4.4.HYPODERMIC NEEDLES

4.4.1.Key market trends
4.4.2.Key growth factors and opportunities
4.4.3.Market size and forecast

4.5.INFUSION PUMPS

4.5.1.Key market trends
4.5.2.Key growth factors and opportunities
4.5.3.Market size and forecast

4.6.OTHER PRODUCTS

4.6.1.Key market trends
4.6.2.Key growth factors and opportunities
4.6.3.Market size and forecast

Chapter: 5 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY MEDICAL APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.VOLUME EXPANDERS

5.2.1.Market size and forecast

5.3.MEDICATION ADMINISTRATION

5.3.1.Market size and forecast

5.4.BLOOD BASED PRODUCTS

5.4.1.Market size and forecast

5.5.NUTRITION AND BUFFER SOLUTION

5.5.1.Market size and forecast

Chapter: 6 IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY END-USER

6.1.OVERVIEW

6.1.1.Market size and forecast

6.2.HOSPITALS

6.2.1.Market size and forecast

6.3.AMBULATORY SURGICAL CENTERS

6.3.1.Market size and forecast

6.4.CLINICS

6.4.1.Market size and forecast

Chapter: 7 IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY GEOGRAPHY

7.1.OVERVIEW

7.1.1.Market size and forecast

7.2.NORTH AMERICA

7.2.1.Key market trends
7.2.2.Key growth factors and opportunities
7.2.3.Market size and forecast
7.2.4.U.S. market size and forecast
7.2.5.Canada market size and forecast
7.2.6.Mexico market size and forecast

7.3.EUROPE

7.3.1.Key market trends
7.3.2.Key growth factors and opportunities
7.3.3.Market size and forecast
7.3.4.Germany market size and forecast
7.3.5.France market size and forecast
7.3.6.UK market size and forecast
7.3.7.Italy market size and forecast
7.3.8.Spain market size and forecast
7.3.9.Rest of Europe market size and forecast

7.4.ASIA-PACIFIC

7.4.1.Key market trends
7.4.2.Key growth factors and opportunities
7.4.3.Market size and forecast
7.4.4.Japan market size and forecast
7.4.5.China market size and forecast
7.4.6.India market size and forecast
7.4.7.Rest of Asia-Pacific market size and forecast

7.5.LAMEA

7.5.1.Key market trends
7.5.2.Key growth factors and opportunities
7.5.3.Market size and forecast
7.5.4.Latin America market size and forecast
7.5.5.Middle East market size and forecast
7.5.6.Africa market size and forecast

Chapter: 8 COMPANY PROFILES

8.1.BECTON, DICKINSON AND COMPANY

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4. Key Strategic Moves & Developments

8.2. B.BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4.Key Strategic Moves & Developments

8.3.TERUMO MEDICAL CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4.Key Strategic Moves & Developments

8.4.TELEFLEX MEDICAL INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4.Key Strategic Moves & Developments

8.5.MEDTRONIC INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4. Key Strategic Moves & Developments

8.6.SMITH & NEPHEW PLC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4.Key Strategic Moves & Developments

8.7.ANGIODYNAMICS, INC.

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4.Key Strategic Moves & Developments

8.8.PFIZER INC.

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4. Key Strategic Moves & Developments

8.9.INSULET CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4. Key Strategic Moves & Developments

8.10.FRESENIUS SE & CO. KGAA

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4. Key Strategic Moves & Developments

LIST OF TABLES

TABLE 1.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR IMPLANTABLE PORT, BY TYPE, 2016-2023 ($MILLION)
TABLE 3.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4.GLOBAL IMPLANTABLE PORT MARKET FOR SINGLE LUMEN IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5.GLOBAL IMPLANTABLE PORT MARKET FOR DOUBLE LUMEN IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETER, BY TYPE, 2016-2023 ($MILLION)
TABLE 7.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERAL INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9.GLOBAL INTRAVENOUS CATHETER MARKET FOR CENTRAL INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERALLY INSERTED CENTRAL CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR HYPODERMIC NEEDLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INFUSION PUMPS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR OTHER PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION,  2016-2023 ($MILLION)
TABLE 15.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR VOLUME EXPANDERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR MEDICATION ADMINISTRATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR BLOOD BASED PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR NUTRITION AND BUFFER SOLUTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER,  2016-2023 ($MILLION)
TABLE 20.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR CLINICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY TYPE, 2016-2023 ($MILLION)
TABLE 26.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY END-USER, 2016-2023 ($MILLION)
TABLE 28.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION,  2016-2023 ($MILLION)
TABLE 31.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 32.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY TYPE, 2016-2023 ($MILLION)
TABLE 34.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET,  BY END-USER, 2016-2023 ($MILLION)
TABLE 36.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY,  2016-2023 ($MILLION)
TABLE 37.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION,  2016-2023 ($MILLION)
TABLE 39.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 40.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 41.B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 42.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 43.TELEFLEX MEDICAL INC.: COMPANY SNAPSHOT
TABLE 44.MEDTRONIC INC.: COMPANY SNAPSHOT
TABLE 45.SMITH & NEPHEW PLC.: COMPANY SNAPSHOT
TABLE 46.ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
TABLE 47.PFIZER INC.: COMPANY SNAPSHOT
TABLE 48.INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 49.FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1.MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKETS
FIGURE 3.TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4.TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5.TOP PLAYER POSITIONING: IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016
FIGURE 1.PERCENTAGE DISTRIBUTION OF POPULATION AGED 65 AND OVER BY REGION: 2015 AN D 2050
FIGURE 2.GLOBAL CHRONIC DIEASES DEATH, 2015 (MILLIIONS)
FIGURE 3.ROAD TRAFFIC ACCIDENTS DEATH RATES OF SOME COUNTRIES
FIGURE 4.GLOBAL IMPLANTABLE PORT MARKET FOR SINGLE LUMEN IMPLANTABLE PORT, 2016-2023 ($MILLION)
FIGURE 5.GLOBAL IMPLANTABLE PORT MARKET FOR DOUBLE LUMEN IMPLANTABLE PORT, 2016-2023 ($MILLION)
FIGURE 6.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERAL INTRAVENOUS CATHETER, 2016-2023 ($MILLION)
FIGURE 7.GLOBAL INTRAVENOUS CATHETER MARKET FOR CENTRAL INTRAVENOUS CATHETER, 2016-2023 ($MILLION)
FIGURE 8.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERALLY INSERTED CENTRAL CATHETER, 2016-2023 ($MILLION)
FIGURE 9.U.S. IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 10.CANADA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 $MILLION)
FIGURE 11.MEXICO IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 12.GERMANY IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 13.FRANCE IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 14.UK IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 15.ITALY IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 16.SPAIN IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 17.REST OF EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET,  2016-2023 ($MILLION)
FIGURE 18.JAPAN IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 19.CHINA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 20.INDIA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21.REST OF ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22.LATIN AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23.MIDDLE EAST IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24.AFRICA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)

 

IV therapy is the process of infusion of liquid substance, such as nutrients, buffer solution, blood & blood components, and medicines, directly into the vein for faster treatment from the diseases. There are different products used in IV therapy such as implantable ports, hypodermic needles, intravenous catheters, and others. Further, Intravenous catheters gained the highest market share. These catheters possess anti-reflux valve, which avoids leakage during and after catheterization.

North America held the highest share attributed to the developed healthcare system, presence of leading product manufacturers, higher adoption of advanced and efficient vein access devices, heavy inflow of investment in R&D, and surge in the number of patients with chronic diseases. According to vital statistics issued by Centre for Disease Control and Prevention (CDC), 633,842 deaths occurred due to heart disease, 155,041 due to chronic respiratory disease, 79,535 due to diabetes, and 146,571 due to unintentional injury in 2015. These factors boost the growth of the IV therapy and vein access devices market in North America. Moreover, rise in preventive healthcare among the population is expected to present growth opportunities for the market players in the near future. Asia-Pacific has the highest market potential as the number of patients suffering from chronic diseases, such as cancer, viral infections, heart diseases, type 2 diabetes, kidney failure, and others, has increased considerably. Moreover, there is a significant increase in the number of well-equipped hospitals with advanced healthcare systems to cater to the needs of the large patient population, which drives the Asia-Pacific IV therapy and vein access devices market. Major companies involved in the IV therapy and vein access devices market are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Medical Corporation, and Teleflex Medical Inc.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Intravenous (IV) Therapy and Vein Access Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts